Chattem's Ban
This article was originally published in The Tan Sheet
Executive Summary
Deep discounting of the antiperspirant line during December by former owner Bristol-Myers Squibb resulted in "pantry loading," causing product sales to remain soft during Chattem's second quarter ending May 31, the Chattanooga-based company says. Chattem purchased the antiperspirant/deodorant franchise March 24 ("The Tan Sheet" March 2, p. 3). Overall, the addition of Ban and the performance of the Sunsource dietary supplement line drove Chattem's sales up 49.4% to $58.5 mil. for the quarter. Net income for the quarter rose to $8.2 mil. from $3.1 mil. last year, although the gain reflects both $6.5 mil. from the sale of the Cornsilk brand and a $1.9 mil. extraordinary loss for early extinguishment of debt...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning